These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15165833)

  • 1. Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist.
    More JC; Nistico R; Dolman NP; Clarke VR; Alt AJ; Ogden AM; Buelens FP; Troop HM; Kelland EE; Pilato F; Bleakman D; Bortolotto ZA; Collingridge GL; Jane DE
    Neuropharmacology; 2004 Jul; 47(1):46-64. PubMed ID: 15165833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonists.
    Dolman NP; More JC; Alt A; Knauss JL; Pentikäinen OT; Glasser CR; Bleakman D; Mayer ML; Collingridge GL; Jane DE
    J Med Chem; 2007 Apr; 50(7):1558-70. PubMed ID: 17348638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.
    Dolman NP; Troop HM; More JC; Alt A; Knauss JL; Nistico R; Jack S; Morley RM; Bortolotto ZA; Roberts PJ; Bleakman D; Collingridge GL; Jane DE
    J Med Chem; 2005 Dec; 48(24):7867-81. PubMed ID: 16302825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel antagonist 3-CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C-fibres.
    More JC; Troop HM; Jane DE
    Br J Pharmacol; 2002 Dec; 137(7):1125-33. PubMed ID: 12429586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists.
    More JC; Troop HM; Dolman NP; Jane DE
    Br J Pharmacol; 2003 Mar; 138(6):1093-100. PubMed ID: 12684265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacological investigation of the role of GLUK5-containing receptors in kainate-driven hippocampal gamma band oscillations.
    Brown JT; Teriakidis A; Randall AD
    Neuropharmacology; 2006 Jan; 50(1):47-56. PubMed ID: 16153668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of recombinant and native GluK3-containing kainate receptors.
    Perrais D; Pinheiro PS; Jane DE; Mulle C
    Neuropharmacology; 2009 Jan; 56(1):131-40. PubMed ID: 18761361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies on N3-substituted willardiine derivatives acting as AMPA or kainate receptor antagonists.
    Dolman NP; More JC; Alt A; Knauss JL; Troop HM; Bleakman D; Collingridge GL; Jane DE
    J Med Chem; 2006 Apr; 49(8):2579-92. PubMed ID: 16610801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glutamate receptor agonists and antagonists on Ca2+ uptake in rat hippocampal slices lesioned by glucose deprivation or by kainate.
    Alici K; Gloveli T; Schmitz D; Heinemann U
    Neuroscience; 1997 Mar; 77(1):97-109. PubMed ID: 9044378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre function.
    Dargan SL; Clarke VR; Alushin GM; Sherwood JL; Nisticò R; Bortolotto ZA; Ogden AM; Bleakman D; Doherty AJ; Lodge D; Mayer ML; Fitzjohn SM; Jane DE; Collingridge GL
    Neuropharmacology; 2009 Jan; 56(1):121-30. PubMed ID: 18789344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological differentiation of kainate receptors on neonatal rat spinal motoneurones and dorsal roots.
    Thomas NK; Hawkins LM; Miller JC; Troop HM; Roberts PJ; Jane DE
    Neuropharmacology; 1998; 37(10-11):1223-37. PubMed ID: 9849660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of different kainate receptor subunits to the properties of recombinant homomeric and heteromeric receptors.
    Fisher MT; Fisher JL
    Neuroscience; 2014 Oct; 278():70-80. PubMed ID: 25139762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.
    Fisher JL; Housley PR
    Cell Mol Neurobiol; 2013 Nov; 33(8):1099-108. PubMed ID: 23975096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
    Pittaluga A; Bonfanti A; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional kainate-selective glutamate receptors in cultured hippocampal neurons.
    Lerma J; Paternain AV; Naranjo JR; Mellström B
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11688-92. PubMed ID: 7505445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine.
    Patneau DK; Mayer ML; Jane DE; Watkins JC
    J Neurosci; 1992 Feb; 12(2):595-606. PubMed ID: 1371315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit.
    Fisher JL
    Neuropharmacology; 2014 Oct; 85():9-17. PubMed ID: 24859608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent pharmacological activity of novel marine-derived excitatory amino acids on glutamate receptors.
    Sanders JM; Ito K; Settimo L; Pentikäinen OT; Shoji M; Sasaki M; Johnson MS; Sakai R; Swanson GT
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1068-78. PubMed ID: 15914675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons.
    Wong LA; Mayer ML; Jane DE; Watkins JC
    J Neurosci; 1994 Jun; 14(6):3881-97. PubMed ID: 7515954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dicarboxyphenylglycines antagonize AMPA- but not kainate-induced depolarizations in neonatal rat motoneurones.
    Thomas NK; Clayton P; Jane DE
    Eur J Pharmacol; 1997 Nov; 338(2):111-6. PubMed ID: 9455991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.